Korean J Parasitol.
1974 Dec;12(2):135-140. 10.3347/kjp.1974.12.2.135.
Clinical trial of Tinidazole (Fasigyn) in acute and chronic intestinal amoebiasis
- Affiliations
-
- 1Department of Pharmacology, College of Medicine, Seoul National University, Korea.
- KMID: 1384292
- DOI: http://doi.org/10.3347/kjp.1974.12.2.135
Abstract
- Tinidazole (Fasigyn), a new drug which is active in vitro and in vivo against Entamoeba histolytica, was used in 30 Korean patients with acute and chronic intestinal amoebiasis. In aute amoebic dysentry eight of ten patients given tinidazole 150 mg q.i.d. for 10 days were cured clinically and parasitologically. In chronic intestinal amoebiasis, the parasitological cure was obtained 6 out of 10 patients given150 mg q.i.d. for 10 days and 8 out of 10 in patients given 300 mg q.i.d. for 7 days. Tinidazole is well tolerated and is free from serious toxicity. There was no significant alteration in blood count, liver function tests and urine analysis of any of the patients treated with tinidazole.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Fasigyn(Tinidazole) versus cefuroxime sodium and amikacin sulfate in abdominal hysterectomy
- Parasitic Diseases as the Cause of Death of Prisoners of War during the Korean War (1950-1953)
- A Case of Megacystis Associated with Primary Chronic Intestinal Pseudoobstruction
- The epidemiology of amoebiasis in Thi-Qar Province, Iraq (2015-2020): differentiation of Entamoeba histolytica and Entamoeba dispar using nested and real-time polymerase chain reaction
- Generalized Peritonitis due to Acute Fulminant Amoebic Colitis
